Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Current Leases: 2022-2023

Historic Current Leases for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to $500,000.

  • Candel Therapeutics' Current Leases rose 10.62% to $500,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $500,000, marking a year-over-year increase of 10.62%. This contributed to the annual value of $464,000 for FY2022, which is N/A change from last year.
  • Latest data reveals that Candel Therapeutics reported Current Leases of $500,000 as of Q3 2023, which was up 2.46% from $488,000 recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Current Leases ranged from a high of $500,000 in Q3 2023 and a low of $429,000 during Q1 2022.
  • Moreover, its 2-year median value for Current Leases was $464,000 (2022), whereas its average is $464,143.
  • Data for Candel Therapeutics' Current Leases shows a peak YoY increased of 10.96% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Candel Therapeutics' Current Leases stood at $464,000 in 2022, then increased by 10.62% to $500,000 in 2023.
  • Its Current Leases stands at $500,000 for Q3 2023, versus $488,000 for Q2 2023 and $476,000 for Q1 2023.